We have shown an interaction between ABO and placental alkaline phosphatase (PAP) polymorphisms (Am. J. Hum. Genet. 24. 495. 1972) suggesting that allele plfl of PAP partially protects fetuses of blood group B from the damaging effects of antibodies produced by ABO incompatible mothers. On the contrary. ABO compatible fetuses are at a disadvantage. since "som" maternal immunological reaction is necessary for the implantation and maintenance of the zygote in utero. Since XY zygotes are antigenlcally more dissimilar from their mothers than X X zygotes, we expected a high M/F ratio in newborn infants of group 8 compatible with their mothers. The study of a consecutive series of 2296 newborns showed a M/F ratio of 1.86 among group B compatible infants. This deviation of the sex ratio from that of the general population (1. 1.05) is highly significant (P <0.01) and further supports our hypothesis that PAP plays an important role in the maternal-fetal imunological relationship.
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DECREASED OUABAIN BINDING IN CYSTIC FIBROSIS FIBRO-
488 BLASTS. J.L. Breslow and J. Epstein, (Spon. by P.S. Gerald), Harvard Medical School and the Children's Hospital Medical Center, Dept. of Medicine, Boston. We have compared the sensitivities of normal and cystic fibrosis (CF) skin fibroblasts to the cytotoxic effects of ouabain (OB), a cardiac glycoside known to inhibit the transport of ions across cell membranes. Cells from 9 unrelated CF patients when plated at low density for 24 hours in K+ deficient medium and then exposed for 24 hours to OB at concentrations from 1 X 10-lo to 1 X 10-6~. show an increased survival when compared to normal cells. In agreement with these observations, studies of 3H-OB binding show that CF cells bind less 08 than normal cells in medium lacking K+. At low drug concentrations (2-20 X ~O-~M), the first order rate constant for 3~-~~ binding in CF cells was approximately 70% of normal. Equilibrium binding experiments were performed in 3 sets of fibroblast strains from age-matched normal and CF individuals. In a Scatchard analysis the CF strains had 84 + 2%. 56 _+ 1%. and 88 f 2% (mean * S.E.M) of normal 3~-~~ binding sites per mg cell protein (for each strain the difference from normal is p < .001). Previous studies by others of OB resistant mammalian cells isolated in culture showed decreased OB binding as well as a decreased ability of OB to inhibit ion trans ort. We have studied ion flux in normal and CF cells using apttb, a potassium analogue, and have shown identical inhibition of ion transport by OB in both cell types. Thus CF cells appear different from other previously described 0B resistant cells. The relationship of these observations to the primary genetic defect in CF is not yet clear. The oral administration of L-5-HTP and carbidopa to children with the Lesch-Nyhan syndrome has been reported to reduce the rate of self-mutilative behavior. In experimental animals, drugs which decrease brain serotonin induce aggressive behavior which is reversed by serotonin's immediate precursor L-5-HTP. A 6 m. old male with a complete deficiency of HGPRT was placed on L-5-HlP initially 24 mg twice a day and carbidopa 12.5 mg twice a day. Prior to therapy. CFS was obtained for 5-HIM, HVA and amino acids. and repeated at 24 and 60 days of therapy. Thereafter, L-5-HTP was increased to 24 mg four times a day. CFS 5-HIM, the metabolite of serotonin and HVA, the major metabolite of dopamine, were assayed by spectrophotofluorimetry, and amino acids by column chromatography. An increase in 5-HIM was detected during theraw e.g., 45.9 nglml prior, and 170, and 123 nglml on therapy. After 12 m. of therapy, a one-day probenecid turnover study (100 mglkg, divided into four doses) was done with the patient on and repeated off therapy. On therapy, CFS 5-HIM pre-probenecid was 24.0 and after probenecid was 365.7 nglm1,while off therapy after probenecid it was 77.6 nglml. CFS HVA and amino acids were not effectd by therapy. This study indicated that L-5-HTP and carbidopa given orally specifically increase the turnover of serotonin.
THE MECHANISM OF
Supported To further identif the kin cs of these transport phenomena studies utilizing '&Cu and ' " C d were performed in MKHS and normal fibroblasts. MKHS and normal cells were grown in Cd-containing medium (Cd concentration = 1.5 pglml, lo9cd concentration 0.15 pg/ml, spec. act. = 17.8 pCi/)Jg) for 20 hours, chased with non-radioactive medium and analyzed at 0, 5, 10, 20 hours.
Hours ( Goka et al. (Pediatr. Res.g:365,1976) indicated increased uptake of %Tby MKHS fibroblasts. Our studies of lo9cd uptake suggest nearly equivalent uptake by MKHS and normal fibroblasts (MKHS/normal -0.9-1.8). These data imply that the observed apparent increased uptake is not the primary phenomenon. for MKHS x. 30 pglml for normals. At Cu concentrations in the medium below 20 pglml, the Cu content of MKHS cells is twice that of normal cells, while from 30-45 ~lglml the intracellular Cu concentrations of MKHS and normal cells approach unity. These data indicate an inability of MKHS fibroblasts to handle Cu normally at all concentrations. The Cu induction profile of MKHS fibroblasts demonstrates a decrease in cadmium (Cd)-mercaptide absorption at 250 nm in the fraction corresponding to metallothionein (FIT).which implies an increased affinity of FIT for Cu. In basal medium decreased intracellular Cd levels exist in MKHS fibroblasts. Cd-induction (0.1-1.5 yglml) experiments indicate increased uptake by MKHS fibroblasts compared to normals. The ratio of MKHS [Cdllnorma1 [Cd] (ngmlmg protein or nglpg DNA) ranged from 1.1-1.9 through out the Cd-induction range. These results, together with the Zn, Cu, and Cd content of the metallothioneins as determined by atomic absorption spectroscopy, are compatible with an abnormal MT and defective Cu efflux for cultured MKHS fibroblasts.
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